Literature DB >> 33749898

Attachment-based family therapy in the age of telehealth and COVID-19.

Suzanne Levy1, Syreeta Mason1, Jody Russon1,2, Guy Diamond1.   

Abstract

The COVID-19 pandemic has transformed so many aspects of our lives. For psychotherapists, telehealth is likely a permanent part of the future mental health landscape. For family therapists using a manualized treatment, this brings unique challenges and creative opportunities. In this article, we describe the adaptation of attachment-based family therapy (ABFT) in the context of telehealth and COVID-19. ABFT is an empirically supported treatment model designed for adolescents and young adults struggling with depression, anxiety, trauma, and suicide. ABFT is a semi-structured, process-oriented, and trauma-informed family therapy model which presents its own unique challenges and benefits in telehealth environments. We present our adaptations based on years of telehealth clinical experience and address how this model supports the impact of COVID-19 on families.
© 2021 American Association for Marriage and Family Therapy.

Entities:  

Keywords:  ABFT; COVID-19; telehealth

Year:  2021        PMID: 33749898     DOI: 10.1111/jmft.12509

Source DB:  PubMed          Journal:  J Marital Fam Ther        ISSN: 0194-472X


  3 in total

1.  COVID-19 and the opportunity for gender-responsive virtual and remote substance use treatment and harm reduction services.

Authors:  Melissa Perri; Rose A Schmidt; Adrian Guta; Nat Kaminski; Katherine Rudzinski; Carol Strike
Journal:  Int J Drug Policy       Date:  2022-08-08

Review 2.  Healthcare Professionals' Experience of Performing Digital Care Visits-A Scoping Review.

Authors:  Ieva Lampickienė; Nadia Davoody
Journal:  Life (Basel)       Date:  2022-06-17

3.  The positive role of parental attachment and communication in Chinese adolescents' health behavior and mental health during COVID-19.

Authors:  Beiming Yang; Bin-Bin Chen; Yang Qu; Yuanfei Zhu
Journal:  J Adolesc       Date:  2022-08-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.